NASDAQ · OCSAW
Oculis Holding AG Warrants financials
$2.74−1.76%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — |
| Operating income | -$104.4M | -$81.8M | -$97.0M |
| Net income | -$124.7M | -$95.0M | -$105.6M |
| Net margin | — | — | — |
| Diluted EPS | $-2.39 | $-2.35 | $-3.53 |
| EBITDA | -$103.7M | -$81.3M | -$55.2M |
| Operating cash flow | -$83.6M | -$54.2M | -$65.4M |
| Free cash flow | -$83.9M | -$54.4M | -$65.5M |
| Diluted shares | 52.2M | 40.4M | 29.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $102.5M | $30.7M | $45.6M |
| Short-term investments | $165.9M | $78.6M | $63.4M |
| Total debt | $0.00 | $0.00 | $449.5K |
| Total assets | $297.3M | $133.2M | $136.0M |
| Total liabilities | $50.3M | $52.0M | $24.5M |
| Shareholders' equity | $247.1M | $81.2M | $111.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology